Laurus Labs Quarterly Results for Trading Insights

LAURUSLABS • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹195 Cr
QSept 2025
Quarterly Results

Laurus Labs Quarterly Results Key Highlights

  • Revenue of ₹1,680 Cr in Sept 2025 (-5.6% vs Mar 2025, +36.8% vs Sept 2024)
  • Net Profit of ₹195 Cr in Sept 2025 (-16.3% vs Mar 2025, +875.0% vs Sept 2024)
  • EBITDA of ₹430 Cr in Sept 2025 (-10.2% vs Mar 2025)
  • Operating Margin of 24.0% in Sept 2025 (+0.0pp vs Mar 2025)
  • Earnings Per Share of ₹3.61 in Sept 2025 (-16.8% vs Mar 2025)

Laurus Labs Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Sept 2024 Mar 2024 QoQ YoY
Revenue (₹ Cr) 1,680 1,779 1,580 1,228 1,458 -5.6% 36.8%
Net Profit (₹ Cr) 195 233 162 20 75 - -
EBITDA (₹ Cr) 430 479 393 183 260 - -
EPS (₹) 3.61 4.34 3.02 0.37 1.40 - -
Operating Margin (%) 24.0% 24.0% 24.0% 15.0% 17.0% - -

Laurus Labs Share Price Trend Around Quarterly Results

Visualize Laurus Labs's 1-year price movement across quarterly results — ideal for logging trades in Laurus Labs share price chart using Tickjournal. All values in ₹.

Related Pages for Laurus Labs

Additional stock information and data for LAURUSLABS

LAURUSLABS company valuation
LAURUSLABS shareholder distribution
LAURUSLABS share price data
LAURUSLABS fair price
LAURUSLABS investment value
LAURUSLABS P/E comparison
Laurus Labs yearly highs lows
LAURUSLABS income statement

Profitability Ratios

Profit Margin 11.6%
EBITDA Margin 25.6%
Operating Margin 24.0%
ROE (Annual) 16.9%

Balance Sheet Highlights

Total Assets ₹9,336 Cr
Total Equity ₹4,603 Cr
Current Assets ₹4,332 Cr
Current Liabilities ₹1,193 Cr

Cash Flow Analysis

Operating Cash Flow ₹602 Cr
Investing Cash Flow ₹-680 Cr
Financing Cash Flow ₹39 Cr
Net Cash Flow ₹-39 Cr

Current Market Data

Current Price ₹1128.50
Exchange NSE
Last Updated Jan 07, 2026

Revenue Trend (₹ Cr)

Sept 2024 1,228
Jun 2025 1,580
Mar 2025 1,779
Sept 2025 1,680

Net Profit Trend (₹ Cr)

Sept 2024 20
Jun 2025 162
Mar 2025 233
Sept 2025 195

Operating Margin Trend (%)

Sept 2024 15.0%
Jun 2025 24.0%
Mar 2025 24.0%
Sept 2025 24.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Laurus Labs quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1782.6 14,875 3,125 +10.8% - 21.0% 137.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 4092.2 3,219 591 +11.3% - 18.4% 233.3
Cipla
Sept 2025 		₹121,238.47 Cr 1467.9 7,716 1,353 +12.0% - 17.5% 87.7
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1242.8 9,135 1,337 +1.1% - 14.6% 76.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores